{
    "clinical_study": {
        "@rank": "129361", 
        "arm_group": {
            "arm_group_label": "Radiolabeled SPD557", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "Phase I study to evaluate the excretion of radioactivity, the metabolic profile,\n      pharmacokinetics, safety and tolerability following a single oral administration of [14C]\n      SPD557 in healthy male volunteers aged 18 to 50 years (inclusive).The purpose of this study\n      is to investigate how and how quickly SPD557 or its break down products are excreted by\n      analysing blood, faeces and urine samples collected during the study."
        }, 
        "brief_title": "Adsorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled SPD557 in Volunteers", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                        "title": "Radiolabelled SSP-002358"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "6"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "6"
                                            }
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "Participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "2.07", 
                                            "@value": "29.5"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "Years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "6"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "Participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "6"
                                        }
                                    }, 
                                    "sub_title": "UNITED STATES"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "Participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Area under the plasma concentration versus time curve from time 0 to infinity.  AUC can be used as a measure of drug exposure. It is derived from drug concentration and time so it gives a measure how much and how long a drug stays in a body.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                                "title": "Radiolabeled SSP-002358"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "13801", 
                                                    "@value": "43476"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Area under the plasma concentration versus time curve from time 0 to infinity.  AUC can be used as a measure of drug exposure. It is derived from drug concentration and time so it gives a measure how much and how long a drug stays in a body.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Area Under the Plasma Concentration Versus Time Curve From Time Zero to Infinity (AUC 0\u2192\u221e) of Radiolabelled SSP-002358", 
                                    "units": "pg*h/ml"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic (PK) Analysis Set included all subjects with at least 1 PK parameter estimated adequately in the Pharmacokinetic Concentration Analysis Set. Pharmacokinetic Concentration Analysis Set included all subjects who took at least 1 dose of investigational product and underwent plasma PK sampling and had evaluable PK assay results.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 240 hours post-dose", 
                        "title": "Area Under the Plasma Concentration Versus Time Curve From Time Zero to Infinity (AUC 0\u2192\u221e) of Radiolabelled SSP-002358", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Cmax is a term that refers to the maximum (or peak) concentration that a drug achieves in the body after the drug has been administered.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                                "title": "Radiolabeled SSP-002358"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "894", 
                                                    "@value": "4643"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Cmax is a term that refers to the maximum (or peak) concentration that a drug achieves in the body after the drug has been administered.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Maximum Plasma Concentration (Cmax) of Radiolabelled SSP-002358", 
                                    "units": "pg/ml"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic (PK) Analysis Set included all subjects with at least 1 PK parameter estimated adequately in the Pharmacokinetic Concentration Analysis Set. Pharmacokinetic Concentration Analysis Set included all subjects who took at least 1 dose of investigational product and underwent plasma PK sampling and had evaluable PK assay results.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 240 hours post-dose", 
                        "title": "Maximum Plasma Concentration (Cmax) of Radiolabelled SSP-002358", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                                "title": "Radiolabeled SSP-002358"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "1.00", 
                                                    "@spread": "1.17", 
                                                    "@upper_limit": "4.00", 
                                                    "@value": "1.25"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "Time to Maximum Plasma Concentration (Tmax) of Radiolabelled SSP-002358", 
                                    "units": "hours"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic (PK) Analysis Set included all subjects with at least 1 PK parameter estimated adequately in the Pharmacokinetic Concentration Analysis Set. Pharmacokinetic Concentration Analysis Set included all subjects who took at least 1 dose of investigational product and underwent plasma PK sampling and had evaluable PK assay results.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 240 hours post-dose", 
                        "title": "Time to Maximum Plasma Concentration (Tmax) of Radiolabelled SSP-002358", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                                "title": "Radiolabeled SSP-002358"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "5"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "2.38", 
                                                    "@value": "11.0"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Plasma Half-Life (T1/2) of Radiolabelled SSP-002358", 
                                    "units": "hours"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic (PK) Analysis Set included all subjects with at least 1 PK parameter estimated adequately in the Pharmacokinetic Concentration Analysis Set. Pharmacokinetic Concentration Analysis Set included all subjects who took at least 1 dose of investigational product and underwent plasma PK sampling and had evaluable PK assay results.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 240 hours post-dose", 
                        "title": "Plasma Half-Life (T1/2) of Radiolabelled SSP-002358", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                                "title": "Radiolabeled SSP-002358"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "41581", 
                                                    "@value": "101960"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "AUC 0\u2192\u221e Whole Blood Total Radioactivity of Radiolabelled SSP-002358", 
                                    "units": "pg equivalents*h/ml"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic (PK) Analysis Set included all subjects with at least 1 PK parameter estimated adequately in the Pharmacokinetic Concentration Analysis Set. Pharmacokinetic Concentration Analysis Set included all subjects who took at least 1 dose of investigational product and underwent plasma PK sampling and had evaluable PK assay results.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 240 hours post-dose", 
                        "title": "AUC 0\u2192\u221e Whole Blood Total Radioactivity of Radiolabelled SSP-002358", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                                "title": "Radiolabeled SSP-002358"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "2138", 
                                                    "@value": "9252"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Cmax Whole Blood Total Radioactivity of Radiolabelled SSP-002358", 
                                    "units": "pg equivalents/ml"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic (PK) Analysis Set included all subjects with at least 1 PK parameter estimated adequately in the Pharmacokinetic Concentration Analysis Set. Pharmacokinetic Concentration Analysis Set included all subjects who took at least 1 dose of investigational product and underwent plasma PK sampling and had evaluable PK assay results.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 240 hours post-dose", 
                        "title": "Cmax Whole Blood Total Radioactivity of Radiolabelled SSP-002358", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                                "title": "Radiolabeled SSP-002358"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "1.00", 
                                                    "@upper_limit": "4.00", 
                                                    "@value": "2.00"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "Tmax Whole Blood Total Radioactivity of Radiolabelled SSP-002358", 
                                    "units": "hours"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic (PK) Analysis Set included all subjects with at least 1 PK parameter estimated adequately in the Pharmacokinetic Concentration Analysis Set. Pharmacokinetic Concentration Analysis Set included all subjects who took at least 1 dose of investigational product and underwent plasma PK sampling and had evaluable PK assay results.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 240 hours post-dose", 
                        "title": "Tmax Whole Blood Total Radioactivity of Radiolabelled SSP-002358", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                                "title": "Radiolabeled SSP-002358"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "1.51", 
                                                    "@value": "6.96"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Half-Life Whole Blood Total Radioactivity of Radiolabelled SSP-002358", 
                                    "units": "hours"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic (PK) Analysis Set included all subjects with at least 1 PK parameter estimated adequately in the Pharmacokinetic Concentration Analysis Set. Pharmacokinetic Concentration Analysis Set included all subjects who took at least 1 dose of investigational product and underwent plasma PK sampling and had evaluable PK assay results.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 240 hours post-dose", 
                        "title": "Half-Life Whole Blood Total Radioactivity of Radiolabelled SSP-002358", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                                "title": "Radiolabeled SSP-002358"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "56101", 
                                                    "@value": "137314"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "AUC 0\u2192\u221e Plasma Total Radioactivity of Radiolabelled SSP-002358", 
                                    "units": "pg equivalents*h/ml"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic (PK) Analysis Set included all subjects with at least 1 PK parameter estimated adequately in the Pharmacokinetic Concentration Analysis Set. Pharmacokinetic Concentration Analysis Set included all subjects who took at least 1 dose of investigational product and underwent plasma PK sampling and had evaluable PK assay results.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 240 hours post-dose", 
                        "title": "AUC 0\u2192\u221e Plasma Total Radioactivity of Radiolabelled SSP-002358", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                                "title": "Radiolabeled SSP-002358"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "3538", 
                                                    "@value": "11658"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Cmax Plasma Total Radioactivity of Radiolabelled SSP-002358", 
                                    "units": "pg equivalents/ml"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic (PK) Analysis Set included all subjects with at least 1 PK parameter estimated adequately in the Pharmacokinetic Concentration Analysis Set. Pharmacokinetic Concentration Analysis Set included all subjects who took at least 1 dose of investigational product and underwent plasma PK sampling and had evaluable PK assay results.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 240 hours post-dose", 
                        "title": "Cmax Plasma Total Radioactivity of Radiolabelled SSP-002358", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                                "title": "Radiolabeled SSP-002358"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "1.00", 
                                                    "@upper_limit": "4.00", 
                                                    "@value": "1.50"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "Tmax Plasma Total Radioactivity of Radiolabelled SSP-002358", 
                                    "units": "hours"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic (PK) Analysis Set included all subjects with at least 1 PK parameter estimated adequately in the Pharmacokinetic Concentration Analysis Set. Pharmacokinetic Concentration Analysis Set included all subjects who took at least 1 dose of investigational product and underwent plasma PK sampling and had evaluable PK assay results.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 240 hours post-dose", 
                        "title": "Tmax Plasma Total Radioactivity of Radiolabelled SSP-002358", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                                "title": "Radiolabeled SSP-002358"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "2.54", 
                                                    "@value": "10.9"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Half-Life Plasma Total Radioactivity of Radiolabelled SSP-002358", 
                                    "units": "hours"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic (PK) Analysis Set included all subjects with at least 1 PK parameter estimated adequately in the Pharmacokinetic Concentration Analysis Set. Pharmacokinetic Concentration Analysis Set included all subjects who took at least 1 dose of investigational product and underwent plasma PK sampling and had evaluable PK assay results.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 240 hours post-dose", 
                        "title": "Half-Life Plasma Total Radioactivity of Radiolabelled SSP-002358", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                                "title": "Radiolabeled SSP-002358"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "10.3", 
                                                    "@value": "38.2"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Percent Total Radioactivity Excreted in Urine of Radiolabelled SSP-002358", 
                                    "units": "percentage of radioactivity"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic (PK) Analysis Set included all subjects with at least 1 PK parameter estimated adequately in the Pharmacokinetic Concentration Analysis Set. Pharmacokinetic Concentration Analysis Set included all subjects who took at least 1 dose of investigational product and underwent plasma PK sampling and had evaluable PK assay results.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 240 hours post-dose", 
                        "title": "Percent Total Radioactivity Excreted in Urine of Radiolabelled SSP-002358", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                                "title": "Radiolabeled SSP-002358"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "10.4", 
                                                    "@value": "57.3"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Percent Total Radioactivity Excreted in Stool of Radiolabelled SSP-002358", 
                                    "units": "percentage of radioactivity"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic (PK) Analysis Set included all subjects with at least 1 PK parameter estimated adequately in the Pharmacokinetic Concentration Analysis Set. Pharmacokinetic Concentration Analysis Set included all subjects who took at least 1 dose of investigational product and underwent plasma PK sampling and had evaluable PK assay results.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 240 hours post-dose", 
                        "title": "Percent Total Radioactivity Excreted in Stool of Radiolabelled SSP-002358", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                        "title": "Radiolabelled SSP-002358"
                    }
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "6", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "6", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "0", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "name_or_title": "Study Physician", 
                "organization": "Shire Development LLC", 
                "phone": "+1 866 842 5335"
            }, 
            "reported_events": {
                "group_list": {
                    "group": {
                        "@group_id": "E1", 
                        "description": "A single oral dose of 2 mg radiolabeled SSP-002358 administered on Day 1", 
                        "title": "Radiolabelled SSP-002358"
                    }
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "6", 
                                            "@subjects_at_risk": "6"
                                        }, 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "7", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "5", 
                                            "@subjects_at_risk": "6"
                                        }, 
                                        "sub_title": "Diarrhoea"
                                    }
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "6"
                                        }, 
                                        "sub_title": "Scratch"
                                    }
                                }, 
                                "title": "Injury, poisoning and procedural complications"
                            }
                        ]
                    }, 
                    "frequency_threshold": "5"
                }
            }
        }, 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Key Inclusion Criteria:\n\n          -  Males ages 18 to 50 years\n\n          -  Have a body mass index (BMI) of \u226518.5 and \u226430 kg/m2\n\n          -  Subject is willing to comply with any applicable contraceptive and sperm donation\n             requirements\n\n        Key Exclusion criteria:\n\n          -  Have participated in a [14C]-study within the last 6 months.\n\n          -  Exposure to clinically significant radiation within 12 months prior to dose (for\n             example, serial X-ray or computed tomography scans, barium meal, current employment\n             in a job requiring radiation exposure monitoring).\n\n          -  Male subjects who consume more than 21 units of alcohol per week or 3 units per day.\n\n          -  Subjects who report typically having more than 2 bowel movements per day, less than 3\n             bowel movements per week or those whose bowel habits have changed significantly\n             within 30 days"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "6", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 6, 2013", 
        "firstreceived_results_date": "February 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01786876", 
            "org_study_id": "SPD557-107"
        }, 
        "intervention": {
            "arm_group_label": "Radiolabeled SPD557", 
            "description": "A single oral dose of 2 mg radiolabeled SPD557 administered on Day 1", 
            "intervention_name": "Radiolabeled SPD557", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "AME", 
            "Radiolabelled"
        ], 
        "lastchanged_date": "April 25, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Madison", 
                    "country": "United States", 
                    "state": "Wisconsin", 
                    "zip": "53704"
                }, 
                "name": "Covance"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase 1 Study to Investigate the Absorption, Metabolism and Excretion of [14C]SPD557 Following a Single Oral Dose in Healthy Male Subjects", 
        "overall_official": {
            "affiliation": "Covance Global Clinical Research Unit Inc.", 
            "last_name": "Stephen Flach", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Area under the plasma concentration versus time curve from time 0 to infinity.  AUC can be used as a measure of drug exposure. It is derived from drug concentration and time so it gives a measure how much and how long a drug stays in a body.", 
                "measure": "Area Under the Plasma Concentration Versus Time Curve From Time Zero to Infinity (AUC 0\u2192\u221e) of Radiolabelled SSP-002358", 
                "safety_issue": "No", 
                "time_frame": "Over 240 hours post-dose"
            }, 
            {
                "description": "Cmax is a term that refers to the maximum (or peak) concentration that a drug achieves in the body after the drug has been administered.", 
                "measure": "Maximum Plasma Concentration (Cmax) of Radiolabelled SSP-002358", 
                "safety_issue": "No", 
                "time_frame": "Over 240 hours post-dose"
            }, 
            {
                "measure": "Time to Maximum Plasma Concentration (Tmax) of Radiolabelled SSP-002358", 
                "safety_issue": "No", 
                "time_frame": "Over 240 hours post-dose"
            }, 
            {
                "measure": "Plasma Half-Life (T1/2) of Radiolabelled SSP-002358", 
                "safety_issue": "No", 
                "time_frame": "Over 240 hours post-dose"
            }, 
            {
                "measure": "AUC 0\u2192\u221e Whole Blood Total Radioactivity of Radiolabelled SSP-002358", 
                "safety_issue": "No", 
                "time_frame": "Over 240 hours post-dose"
            }, 
            {
                "measure": "Cmax Whole Blood Total Radioactivity of Radiolabelled SSP-002358", 
                "safety_issue": "No", 
                "time_frame": "Over 240 hours post-dose"
            }, 
            {
                "measure": "Tmax Whole Blood Total Radioactivity of Radiolabelled SSP-002358", 
                "safety_issue": "No", 
                "time_frame": "Over 240 hours post-dose"
            }, 
            {
                "measure": "Half-Life Whole Blood Total Radioactivity of Radiolabelled SSP-002358", 
                "safety_issue": "No", 
                "time_frame": "Over 240 hours post-dose"
            }, 
            {
                "measure": "AUC 0\u2192\u221e Plasma Total Radioactivity of Radiolabelled SSP-002358", 
                "safety_issue": "No", 
                "time_frame": "Over 240 hours post-dose"
            }, 
            {
                "measure": "Cmax Plasma Total Radioactivity of Radiolabelled SSP-002358", 
                "safety_issue": "No", 
                "time_frame": "Over 240 hours post-dose"
            }, 
            {
                "measure": "Tmax Plasma Total Radioactivity of Radiolabelled SSP-002358", 
                "safety_issue": "No", 
                "time_frame": "Over 240 hours post-dose"
            }, 
            {
                "measure": "Half-Life Plasma Total Radioactivity of Radiolabelled SSP-002358", 
                "safety_issue": "No", 
                "time_frame": "Over 240 hours post-dose"
            }, 
            {
                "measure": "Percent Total Radioactivity Excreted in Urine of Radiolabelled SSP-002358", 
                "safety_issue": "No", 
                "time_frame": "Over 240 hours post-dose"
            }, 
            {
                "measure": "Percent Total Radioactivity Excreted in Stool of Radiolabelled SSP-002358", 
                "safety_issue": "No", 
                "time_frame": "Over 240 hours post-dose"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01786876"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Shire", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shire", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}